AHR and Alzheimer disease: Dysfunction of the AhR pathway in AD, characterized by increased AhR expression but reduced pathway activation, suggests a complex interplay between AhR and the inflammatory milieu in AD, necessitating further investigation into its therapeutic modulation [1].